Financial statements Dr Vist Chemicals Europe
Balance sheet data of DR VIST CHEMICALS EUROPE
|
Year
|
2016
|
2018
|
2019
|
|---|---|---|---|
| Total assets | 35 907,06 | 125 320,80 | 111 047,55 |
| A. Fixed assets | 0,00 | 0,00 | 84 640,41 |
| B. Current assets | 35 907,06 | 125 320,80 | 26 407,14 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 35 907,06 | 125 320,80 | 111 047,55 |
| A. Equity | 6 267,90 | 24 031,08 | 12 990,75 |
| B. Liabilities and provisions for liabilities | 29 639,16 | 101 289,72 | 98 056,80 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | 29 639,16 | 101 289,72 | 83 248,01 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.